Early administration of pegfilgrastim contributes to the safety of DCF therapy as neoadjuvant chemotherapy for esophageal cancer

被引:0
|
作者
Morita, Ryuichi [1 ]
Ishikawa, Takeshi [1 ,2 ]
Endo, Yuki [1 ]
Yasuda, Takeshi [1 ]
Oka, Kaname [1 ]
Sakakida, Tomoki [1 ]
Matsumura, Shinya [1 ]
Mizushima, Katsura [1 ]
Doi, Toshifumi [1 ]
Okayama, Tetsuya [1 ]
Katada, Kazuhiro [1 ]
Kamada, Kazuhiro [1 ]
Uchiyama, Kazuhiko [1 ]
Takagi, Tomohisa [1 ]
Fujiwara, Hitoshi [3 ]
Konishi, Hideyuki [1 ]
Itoh, Yoshito [1 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Mol Gastroenterol & Hepatol, Kyoto, Japan
[2] Kyoto Prefectural Univ Med, Univ Hosp, Outpatient Oncol Unit, Kyoto, Japan
[3] Grad Sch Med Sci, Div Digest Surg, Dept Surg, Kyoto, Japan
关键词
D O I
10.1016/j.annonc.2023.09.258
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MO40-5
引用
下载
收藏
页码:S1422 / S1422
页数:1
相关论文
共 50 条
  • [31] Neoadjuvant therapy for resectable esophageal cancer
    Hejna, M
    Raderer, M
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2005, 43 (10): : 1141 - 1147
  • [32] Neoadjuvant chemotherapy with or without neoadjuvant radiotherapy compared with neoadjuvant chemoradiotherapy for esophageal cancer
    Zheng, Yan
    Liu, Xianben
    Zhang, Ruixiang
    Wang, Zongfei
    Sun, Haibo
    Qin, Jianjun
    Liu, Shilei
    Li, Yin
    JOURNAL OF THORACIC DISEASE, 2018, 10 (08) : 4715 - 4723
  • [33] Safety of same day administration of pegfilgrastim in breast cancer patients
    Reynolds, Kathryn
    Katz, Julia
    Nabell, Lisle
    Grant, Stefan C.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Safety and efficacy of pegfilgrastim administration on the same day as myelosuppressive chemotherapy (CT) in women with ovarian or primary peritoneal cancer
    Schuman, S. I.
    Lambrou, N.
    Robson, K.
    Gluck, S.
    Myriounis, N.
    Pearson, J.
    Alvarez, E.
    Crisp, M. P.
    Twiggs, L. B.
    Lucci, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Safety and efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (Neo DCF) therapy for locally advanced esophageal cancer: Real world data analysis.
    Tamba, Mikako
    Osumi, Hiroki
    Fukuoka, Shota
    Ogura, Mariko
    Okamura, Akihiko
    Kanamori, Jun
    Imamura, Yu
    Takahari, Daisuke
    Yoshino, Koichiro
    Udagawa, Shohei
    Wakatsuki, Takeru
    Shinozaki, Eiji
    Watanabe, Masayuki
    Yamaguchi, Kensei
    Chin, Keisho
    Ooki, Akira
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 365 - 365
  • [36] Efficacy and safety of early administration of pegfilgrastim in patients with esophageal cancer treated by docetaxel, cisplatin, and 5-fluorouracil (OCR: a phase 2 prospective study
    Ishikawa, T.
    Yasuda, T.
    Okayama, T.
    Konishi, H.
    Naito, Y.
    Taguchi, T.
    Itoh, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [37] Neoadjuvant chemotherapy for early breast cancer
    Krug, David
    Loibl, Sibylle
    LANCET ONCOLOGY, 2018, 19 (03): : E129 - E129
  • [38] Neoadjuvant chemotherapy for early breast cancer
    Mieog, J. Sven D.
    van de Velde, Cornelis J. H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (09) : 1423 - 1434
  • [39] Comparison of efficacy and safety between pembrolizumab combined with chemotherapy and simple chemotherapy in neoadjuvant therapy for esophageal squamous cell carcinoma
    Huang, Bingjiang
    Shi, Haiyan
    Gong, Xiaohua
    Yu, Jing
    Xiao, Caixia
    Zhou, Bin
    Liang, Zibin
    Li, Xiaojian
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (05) : 2013 - 2021
  • [40] Efficacy and safety of neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in locally advanced esophageal cancer: An updated meta-analysis
    Liang, Zhanpeng
    Chen, Ting
    Li, Wenxia
    Lai, Huiqin
    Li, Luzhen
    Wu, Jiaming
    Zhang, Huatang
    Fang, Cantu
    MEDICINE, 2024, 103 (03) : E36785